INFANRIX HEXA

INJ PLS SUS 10+10X0,5ML ISP+20J

SÚKL code 0025646
Name of the product INFANRIX HEXA
_MA_MEDICATION_DETAIL_INFO_MED_NAME i INFANRIX HEXA
Supplement INJ PLS SUS 10+10X0,5ML ISP+20J
Strenght
Pharmaceutical form Powder and suspension for suspension for injection
Package 10+10X0,5ML ISP+20J
Route Intramuscular use
Wrap type Vial
Legal status na lékařský předpis
Active substance DIPHTHERIA TOXOID (DIPHTHERIAE ANATOXINUM)
TETANUS TOXOID (TETANI ANATOXINUM)
POLIOMYELITIS VIRUS TYPE 1, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 1 INACTIVATUM)
POLIOMYELITIS VIRUS TYPE 2, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 2 INACTIVATUM)
POLIOMYELITIS VIRUS TYPE 3, INACTIVATED (VIRUS POLIOMYELITIDIS TYPUS 3 INACTIVATUM)
PERTUSSIS TOXOID (PERTUSSIS ANATOXINUM)
PERTUSSIS FILAMENTOUS HAEMAGGLUTININ (PERTUSSIS HAEMAGGLUTININUM FILAMENTOSUM)
PERTACTIN (PERTACTINUM)
HEPATITIS B SURFACE ANTIGEN (TEGIMINIS HEPATITIDIS B ANTIGENUM)
HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (HAEMOPHILI INFLUENZAE TYPI B POLYSACCHARIDUM)
ATC group J07CA09
ATC group name DIFTERIE-HAEMOPHILUS INFLUENZAE B-PERTUSE-POLIOMYELIDA-TETANUS-HEPATITIDA B

Marketing authorisation information

Registration Number EU/1/00/152/006
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder GlaxoSmithKline Biologicals S.A., Rixensart
MA Holder country BELGIE

Back to list